SUMO-1 CRISPR Knockout and Activation Products (h)

SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen

Frontiers Natural Products Against Renal Fibrosis via Modulation of SUMOylation

Mapping cellular responses to DNA double-strand breaks using CRISPR technologies: Trends in Genetics

Frontiers SUMO and SUMOylation Pathway at the Forefront of Host Immune Response

SUMO-4 CRISPR Knockout and Activation Products (h)

PARP1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human PARP-1 gene expression. Cited in 3 publications

PARP1 CRISPR Knockout and Activation Products (h) | SCBT - Santa Cruz Biotechnology

Interferon, restriction factors and SUMO pathways - ScienceDirect

Activation of the PSA gene by ETV1. A, ETV1 or its 6xA mutant (300 ng)

SUMO‐regulated mitochondrial function in Parkinson's disease - Guerra de Souza - 2016 - Journal of Neurochemistry - Wiley Online Library

SUMO1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.

Sumo 1 (SUMO1) Human Gene Knockout Kit (CRISPR)

FAT10 inhibits SUMO activation by AOS1/UBA2. a In vitro

IJMS, Free Full-Text